Chellan Kumarasamy

865 total citations
40 papers, 542 citations indexed

About

Chellan Kumarasamy is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chellan Kumarasamy has authored 40 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cancer Research, 16 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chellan Kumarasamy's work include MicroRNA in disease regulation (13 papers), Circular RNAs in diseases (10 papers) and Cancer-related molecular mechanisms research (8 papers). Chellan Kumarasamy is often cited by papers focused on MicroRNA in disease regulation (13 papers), Circular RNAs in diseases (10 papers) and Cancer-related molecular mechanisms research (8 papers). Chellan Kumarasamy collaborates with scholars based in Australia, India and United States. Chellan Kumarasamy's co-authors include Rama Jayaraj, Shanthi Sabarimurugan, Siddhartha Baxi, Gothandam Kodiveri Muthukaliannan, Madhav Madurantakam Royam, Sunil Krishnan, Ramesh Nachimuthu, Arikketh Devi, Sameep Shetty and Ajay Gupta and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and Thorax.

In The Last Decade

Chellan Kumarasamy

38 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chellan Kumarasamy Australia 12 237 216 192 76 61 40 542
Shanthi Sabarimurugan Australia 12 195 0.8× 188 0.9× 153 0.8× 72 0.9× 39 0.6× 27 443
Hideyuki Sugita Japan 10 51 0.2× 137 0.6× 56 0.3× 140 1.8× 41 0.7× 10 510
Sandhya Kharbanda United States 15 105 0.4× 177 0.8× 72 0.4× 58 0.8× 81 1.3× 48 690
L. Perez Argentina 12 74 0.3× 151 0.7× 144 0.8× 16 0.2× 110 1.8× 32 432
Pichet Sampatanukul Thailand 13 50 0.2× 88 0.4× 114 0.6× 87 1.1× 129 2.1× 43 469
Yong‐Qiao He China 12 63 0.3× 133 0.6× 128 0.7× 57 0.8× 36 0.6× 35 377
Maria Lazariotou Germany 12 65 0.3× 104 0.5× 146 0.8× 47 0.6× 120 2.0× 24 427
Dae Hoon Jeong South Korea 13 53 0.2× 184 0.9× 128 0.7× 50 0.7× 55 0.9× 41 464
Joanna Osada Poland 15 73 0.3× 68 0.3× 171 0.9× 61 0.8× 100 1.6× 37 445

Countries citing papers authored by Chellan Kumarasamy

Since Specialization
Citations

This map shows the geographic impact of Chellan Kumarasamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chellan Kumarasamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chellan Kumarasamy more than expected).

Fields of papers citing papers by Chellan Kumarasamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chellan Kumarasamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chellan Kumarasamy. The network helps show where Chellan Kumarasamy may publish in the future.

Co-authorship network of co-authors of Chellan Kumarasamy

This figure shows the co-authorship network connecting the top 25 collaborators of Chellan Kumarasamy. A scholar is included among the top collaborators of Chellan Kumarasamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chellan Kumarasamy. Chellan Kumarasamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brims, Fraser, et al.. (2023). The Western Australian Mesothelioma Registry: Analysis of 60 years of cases. Respirology. 29(4). 288–294. 5 indexed citations
2.
3.
Sabarimurugan, Shanthi, et al.. (2020). <p>The Significance of miRNAs as a Prognostic Biomarker for Survival Outcome in T Cell – Acute Lymphoblastic Leukemia Patients: A Systematic Review and Meta-Analysis</p>. Cancer Management and Research. Volume 12. 819–839. 7 indexed citations
4.
Sabarimurugan, Shanthi, Madhav Madurantakam Royam, Chellan Kumarasamy, et al.. (2020). Prognostic Value of MicroRNAs in Stage II Colorectal Cancer Patients: A Systematic Review and Meta-Analysis. Molecular Diagnosis & Therapy. 24(1). 15–30. 6 indexed citations
5.
Jayaraj, Rama, Chellan Kumarasamy, Luke J. Norbury, David Piedrafita, & Peter M. Smooker. (2019). Protective efficacy of liver fluke DNA vaccines: A systematic review and meta-analysis: Guiding novel vaccine development. Veterinary Parasitology. 267. 90–98. 2 indexed citations
6.
Royam, Madhav Madurantakam, Shanthi Sabarimurugan, Chellan Kumarasamy, et al.. (2019). miRNA Predictors of Pancreatic Cancer Chemotherapeutic Response: A Systematic Review and Meta-Analysis. Cancers. 11(7). 900–900. 23 indexed citations
7.
Jayaraj, Rama, Madhav Madurantakam Royam, Shanthi Sabarimurugan, et al.. (2019). Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis. Cells. 8(10). 1250–1250. 41 indexed citations
8.
Sabarimurugan, Shanthi, Madhav Madurantakam Royam, Chellan Kumarasamy, et al.. (2019). Prognostic Significance of FOXC1 in Various Cancers: A Systematic Review and Meta-Analysis. Molecular Diagnosis & Therapy. 23(6). 695–706. 16 indexed citations
9.
Jayaraj, Rama, Chellan Kumarasamy, & Madhav Madurantakam Royam. (2019). Practical approaches to interpretation of findings from a systematic review and network meta-analysis on efficacy and resistance of different artemisinin-based combination therapies. Parasitology International. 73. 101949–101949.
10.
Royam, Madhav Madurantakam, Chellan Kumarasamy, Siddhartha Baxi, et al.. (2019). Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies. Molecular Diagnosis & Therapy. 23(1). 65–82. 9 indexed citations
11.
Kumarasamy, Chellan, Madhav Madurantakam Royam, Shanthi Sabarimurugan, et al.. (2019). Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-Analysis. Cells. 8(8). 772–772. 28 indexed citations
12.
Jayaraj, Rama, Chellan Kumarasamy, Shanthi Sabarimurugan, & Madhav Madurantakam Royam. (2019). Conceptual Interpretation and Clinical Validity of Meta-analysis on Vegetarian-Based Dietary Patterns and Their Relation with Inflammatory and Immune Biomarkers. Advances in Nutrition. 10(6). 1177–1178. 1 indexed citations
13.
Jayaraj, Rama & Chellan Kumarasamy. (2019). Comment on “Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis”. British Journal of Cancer. 120(9). 954–955. 3 indexed citations
14.
15.
Sabarimurugan, Shanthi, Chellan Kumarasamy, Siddhartha Baxi, Arikketh Devi, & Rama Jayaraj. (2019). Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma. PLoS ONE. 14(2). e0209760–e0209760. 35 indexed citations
16.
Jayaraj, Rama, Chellan Kumarasamy, David Piedrafita, & Peter M. Smooker. (2018). Systematic review and meta-analysis protocol for Fasciola DNA vaccines. 22(6). 517–524. 7 indexed citations
17.
18.
Jayaraj, Rama, Chellan Kumarasamy, Shanthi Sabarimurugan, & Siddhartha Baxi. (2018). Letter to the Editor in response to the article, “The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis”. Oral Oncology. 84. 121–122. 12 indexed citations
19.
Kumarasamy, Chellan, et al.. (2015). Bioactive proteins from Solanaceae as quorum sensing inhibitors against virulence in Pseudomonas aeruginosa. Medical Hypotheses. 84(6). 539–542. 12 indexed citations
20.
Kumarasamy, Chellan, et al.. (2015). Effect of protein arginine methyltransferase-1 inhibition on hypoxia-induced vasoconstriction. Medical Hypotheses. 85(6). 740–743. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shanthi Sabarimurugan Breakdown of academic impact, for papers by Hideyuki Sugita Breakdown of academic impact, for papers by Sandhya Kharbanda Breakdown of academic impact, for papers by L. Perez Breakdown of academic impact, for papers by Pichet Sampatanukul Breakdown of academic impact, for papers by Yong‐Qiao He Breakdown of academic impact, for papers by Maria Lazariotou Breakdown of academic impact, for papers by Dae Hoon Jeong Breakdown of academic impact, for papers by Joanna Osada
Rankless by CCL
2026